PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go?
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 2, p. 115, doi. 10.1007/s11912-022-01355-4
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2023 AND VI 25 AND IP 2
Results: 8
1
2
Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 2, p. 123, doi. 10.1007/s11912-022-01354-5
- By:
- Publication type:
- Article
3
Management of Stage III Oral Cavity Squamous Cell Carcinoma in Light of the New Staging System: a Critical Review.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 2, p. 107, doi. 10.1007/s11912-022-01353-6
- By:
- Publication type:
- Article
4
Surviving Burnout as an Oncologist.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 2, p. 131, doi. 10.1007/s11912-022-01351-8
- By:
- Publication type:
- Article
5
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 2, p. 83, doi. 10.1007/s11912-022-01350-9
- By:
- Publication type:
- Article
6
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 2, p. 93, doi. 10.1007/s11912-022-01349-2
- By:
- Publication type:
- Article
7
Where Are We Now with Liver Transplantation in Neuroendocrine Neoplasms? The Place of Liver Transplantation for Grades 1 and 2 Well-Differentiated Unresectable Liver Metastatic Neuroendocrine Tumours.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 2, p. 135, doi. 10.1007/s11912-022-01343-8
- By:
- Publication type:
- Article
8
Influence of Perioperative Anesthesia on Cancer Recurrence: from Basic Science to Clinical Practice.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 2, p. 63, doi. 10.1007/s11912-022-01342-9
- By:
- Publication type:
- Article